Advances in research and current challenges in the treatment of advanced HER2-low breast cancer
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.The DESTINY-Breast04 study shows trastuzumab deruxtecan (T-DXd) effectively treats advanced HER2-low breast cancer. This finding expands treatment options for a significant patient population previously underserved by HER2-targeted therapies.
Area Of Science
- Oncology
- Molecular Diagnostics
- Pharmacology
Background
- Human epidermal growth factor receptor 2 (HER2)-low breast cancer, defined by IHC scores of 1+ or 2+ and ISH-negative results, represents a substantial patient subgroup.
- Traditional HER2 classification limits HER2-targeted therapy eligibility to 15%-20% of breast cancer patients.
- Advanced HER2-low breast cancer accounts for approximately half of all advanced breast cancer cases.
Purpose Of The Study
- To evaluate the efficacy of trastuzumab deruxtecan (T-DXd) in patients with advanced HER2-low breast cancer.
- To discuss the current challenges and future directions in the detection and treatment of HER2-low breast cancer.
- To explore the toxicity and resistance mechanisms associated with T-DXd therapy.
Main Methods
- Clinical study (DESTINY-Breast04) assessing T-DXd treatment in advanced HER2-low breast cancer.
- Review of current detection methods and evaluation criteria for HER2-low breast cancer.
- Analysis of T-DXd therapy's safety profile, including toxicity and resistance.
Main Results
- Trastuzumab deruxtecan (T-DXd) demonstrated significant efficacy in patients with advanced HER2-low breast cancer.
- The study highlights T-DXd as a promising therapeutic option for this previously undertreated population.
Conclusions
- T-DXd offers a significant advancement in treating advanced HER2-low breast cancer.
- Standardization of detection methods and further research into T-DXd's toxicity and resistance are crucial.
- This research expands therapeutic strategies for a large segment of advanced breast cancer patients.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...